https://immunebiosolutions.com/actualites/ 2026-01-21T14:24:04+00:00 https://immunebiosolutions.com/en/polyclonal-and-monoclonal-antibodies-why-chickens-beat-mammals-for-human-targets/ 2026-04-22T12:55:15+00:00 https://immunebiosolutions.com/wp-content/uploads/2025/10/image-2.png https://immunebiosolutions.com/wp-content/uploads/2025/11/Polyclonal-6-scaled.jpeg https://immunebiosolutions.com/anticorps-polyclonaux-et-monoclonaux-pourquoi-les-poules-surpassent-les-mammiferes-pour-les-cibles-humaines/ 2026-04-22T12:54:38+00:00 https://immunebiosolutions.com/wp-content/uploads/2025/10/image-2.png https://immunebiosolutions.com/wp-content/uploads/2025/11/Polyclonal-6-scaled.jpeg https://immunebiosolutions.com/anticorps-bispecifiques-et-multi-specifiques-la-chaine-legere-commune-un-atout-cle-des-anticorps-aviaires-humanises/ 2026-02-13T15:15:00+00:00 https://immunebiosolutions.com/wp-content/uploads/2026/02/gr2_lrg-scaled.jpg https://immunebiosolutions.com/wp-content/uploads/2026/02/Bispecific-quote-2-1.jpeg https://immunebiosolutions.com/wp-content/uploads/2026/02/Antibody-Formats-14.jpeg https://immunebiosolutions.com/wp-content/uploads/2026/02/Antibody-Formats-16.jpeg https://immunebiosolutions.com/wp-content/uploads/2026/02/Antibody-Formats-17.jpeg https://immunebiosolutions.com/wp-content/uploads/2026/02/Antibody-and-Protein-Production-1.jpeg https://immunebiosolutions.com/en/bispecific-multispecific-antibodies-the-common-light-chain-and-upper-hand-of-humanized-avian-antibodies/ 2026-02-13T14:16:43+00:00 https://immunebiosolutions.com/wp-content/uploads/2026/02/gr2_lrg-scaled.jpg https://immunebiosolutions.com/wp-content/uploads/2026/02/Bispecific-quote-2-1.jpeg https://immunebiosolutions.com/wp-content/uploads/2026/02/Antibody-Formats-14.jpeg https://immunebiosolutions.com/wp-content/uploads/2026/02/Antibody-Formats-16.jpeg https://immunebiosolutions.com/wp-content/uploads/2026/02/Antibody-Formats-17.jpeg https://immunebiosolutions.com/wp-content/uploads/2026/02/Antibody-and-Protein-Production-1.jpeg https://immunebiosolutions.com/bli-vs-spr-choisir-le-bon-outil-pour-la-decouverte-danticorps/ 2025-11-05T19:29:07+00:00 https://immunebiosolutions.com/wp-content/uploads/2025/10/image.png https://immunebiosolutions.com/wp-content/uploads/2025/10/image-1.png https://immunebiosolutions.com/restez-a-lavant-garde-accelerez-le-developpement-danticorps-ciblant-pd-1-pd-l1-et-dautres-antigenes-grace-a-nos-librairies-immunisees/ 2025-11-05T19:28:47+00:00 https://immunebiosolutions.com/en/safety-and-efficacy-of-inhaled-ibio123-for-severe-covid-19-a-randomised-double-blind-dose-ascending-placebo-controlled-phase-1-2-trial/ 2025-11-05T19:27:51+00:00 https://immunebiosolutions.com/en/bli-vs-spr-picking-the-right-tool-for-biotech-discovery/ 2025-11-05T19:27:21+00:00 https://immunebiosolutions.com/wp-content/uploads/2025/10/image.png https://immunebiosolutions.com/wp-content/uploads/2025/10/image-1.png https://immunebiosolutions.com/en/stay-ahead-of-the-curve-fast-track-antibodies-for-pd-1-pd-l1-and-other-antigens-with-immunized-libraries/ 2025-11-05T19:27:08+00:00 https://immunebiosolutions.com/en/immune-biosolutions-announces-the-appointment-of-nicholas-franco-as-chairman-of-its-board-of-directors/ 2024-07-17T17:15:25+00:00 https://immunebiosolutions.com/wp-content/uploads/2024/07/Nicholas-Franco.jpg https://immunebiosolutions.com/immune-biosolutions-annonce-la-nomination-de-nicholas-franco-a-la-presidence-de-son-conseil-dadministration/ 2024-07-17T17:01:26+00:00 https://immunebiosolutions.com/wp-content/uploads/2024/07/Nicholas-Franco.jpg https://immunebiosolutions.com/securite-et-efficacite-dibio123-inhale-pour-la-covid-19-severe-de-nouveaux-resultats/ 2023-10-10T14:22:13+00:00 https://immunebiosolutions.com/immune-biosolutions-un-pas-de-plus-vers-le-1er-traitement-par-inhalation-danticorps-contre-la-covid-19/ 2023-08-22T01:59:02+00:00 https://immunebiosolutions.com/en/immune-biosolutions-a-step-closer-to-the-first-inhaled-antibody-treatment-for-covid-19/ 2023-08-22T01:57:43+00:00 https://immunebiosolutions.com/en/neomabs-biotechnologies-a-company-dedicated-to-developing-new-immunotherapies-for-cancer-treatment-launches-in-montreal/ 2023-06-07T19:48:06+00:00 https://immunebiosolutions.com/lancement-de-neomabs-biotechnologies-une-entreprise-dediee-au-developpement-de-nouvelles-immunotherapies-pour-le-traitement-du-cancer/ 2023-06-07T13:21:49+00:00 https://immunebiosolutions.com/recherche-et-innovation-en-sciences-de-la-vie-ottawa-et-quebec-accordent-pres-de-18-m-a-immune-biosolutions-pour-contrer-les-epidemies-virales/ 2023-05-17T20:14:54+00:00 https://immunebiosolutions.com/en/appointment-of-a-new-director-to-the-board-of-directors-of-immune-biosolutions-inc/ 2023-05-02T20:00:04+00:00 https://immunebiosolutions.com/nomination-dun-nouvel-administrateur-au-sein-du-conseil-dadministration-dimmune-biosolutions-inc/ 2023-04-26T12:36:27+00:00 https://immunebiosolutions.com/en/cqdm-to-support-a-1-1-million-immune-biosolutions-research-project/ 2023-04-03T14:10:53+00:00 https://immunebiosolutions.com/en/immune-biosolutions-to-participate-to-bio-europe-2018-in-copenhagen/ 2023-03-31T13:31:42+00:00 https://immunebiosolutions.com/en/new-research-collaboration-with-janssen-biotech/ 2023-03-31T13:31:39+00:00 https://immunebiosolutions.com/en/immune-biosolutions-participate-to-futurpreuneurs-growth-accelerator/ 2023-03-31T13:31:36+00:00 https://immunebiosolutions.com/immune-biosolutions-poursuivra-sa-croissance-a-espacelabz/ 2023-03-31T13:31:00+00:00 https://immunebiosolutions.com/immune-biosolutions-selectionnee-pour-les-jlabs/ 2023-03-31T13:30:57+00:00 https://immunebiosolutions.com/immune-biosolutions-to-present-at-iccs-2018/ 2023-03-31T13:30:53+00:00 https://immunebiosolutions.com/le-cqdm-soutient-un-projet-de-11-million-de-dollars-dimmune-biosolutions/ 2023-03-31T13:30:43+00:00 https://immunebiosolutions.com/immune-biosolutions-diex-recherche-luniversite-de-sherbrooke-et-keyrus-life-science-partenaires-dans-la-lutte-contre-la-covid-19/ 2023-03-31T13:29:04+00:00 https://immunebiosolutions.com/immune-biosolutions-recoit-1344-m-pour-developper-et-bio-fabriquer-son-immunotherapie-prometteuse-pour-traiter-la-covid-19-et-ses-variants/ 2023-03-31T13:29:00+00:00 https://immunebiosolutions.com/traitement-prometteur-de-la-covid-19-et-ses-variants-debut-de-lessai-clinique-de-phase-i-pour-limmunotherapie-par-inhalation-de-la-biotech-quebecoise-immune-biosolutions/ 2023-03-31T13:28:56+00:00 https://immunebiosolutions.com/immune-biosolutions-annonce-que-son-principal-produit-immunotherapeutique-ibio123-neutralise-100-des-variants-preoccupants-du-sras-cov-2-y-compris-omicron/ 2023-03-31T13:28:51+00:00 https://immunebiosolutions.com/wp-content/uploads/2022/01/Immune-Biosolution_Logo_Blanc-1.jpg https://immunebiosolutions.com/immune-bio-selectionnee-pour-la-competition-de-pitch-au-g20-yea/ 2023-03-31T13:28:39+00:00 https://immunebiosolutions.com/en/immune-biosolutions-receives-c13-44-million-to-develop-and-biomanufacture-its-promising-immunotherapy-to-treat-covid-19-and-its-variants/ 2023-03-31T13:28:21+00:00 https://immunebiosolutions.com/en/promising-treatment-against-covid-19-and-its-variants-quebec-biotech-immune-biosolutions-begins-phase-i-clinical-trial-stages-for-its-inhaled-immunotherapy-treatment/ 2023-03-31T13:28:16+00:00 https://immunebiosolutions.com/en/immune-biosolutions-reports-that-its-lead-immunotherapy-product-ibio123-neutralizes-100-of-the-sars-cov-2-variants-of-concern-vocs-including-omicron/ 2023-03-31T13:28:11+00:00 https://immunebiosolutions.com/en/immune-bio-selected-for-the-pitch-competition-at-g20-yea/ 2023-03-28T19:27:44+00:00 https://immunebiosolutions.com/en/immune-biosolutions-to-present-at-iccs-2018-2/ 2023-03-28T19:07:48+00:00 https://immunebiosolutions.com/en/immune-biosolutions-diex-recherche-universite-de-sherbrooke-and-keyrus-life-science-partner-up-to-fight-covid-19/ 2023-03-28T19:05:37+00:00 https://immunebiosolutions.com/en/immune-biosolutions-will-continue-its-growth-at-espacelabz/ 2023-03-28T19:03:14+00:00 https://immunebiosolutions.com/en/immune-biosolutions-selected-for-jlabs-toronto/ 2023-03-28T19:02:38+00:00 https://immunebiosolutions.com/en/new-board-of-directors-appointments/ 2023-03-28T18:58:11+00:00 https://immunebiosolutions.com/en/immune-biosolutions-delegates-to-participate-to-bio-convention-2018-in-boston/ 2018-05-18T15:10:12+00:00 https://immunebiosolutions.com/en/immune-biosolutions-to-participate-to-knowledge-for-growth-2018-in-belgium/ 2018-05-10T15:11:22+00:00 https://immunebiosolutions.com/en/immune-biosolutions-to-present-at-bioequity-europe-2018-2/ 2018-05-02T15:12:19+00:00 https://immunebiosolutions.com/en/g-protein-coupled-receptors-targeted-by-antibodies-raised-against-three-dimensional-epitopes/ 2017-01-01T20:00:52+00:00